Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Insitro Appoints Hideo Makimura As Chief Medical Officer

PRIVATESep 08, 2026•about 3 hours ago

Position

Chief Medical Officer

Company

Insitro

Hideo Makimura
San FranciscoBiotechnologyHealth CareTherapeutics

Description

insitro has appointed Hideo Makimura as Chief Medical Officer, effective Sept. 14. He will lead clinical development strategy as the company prepares for first-in-human trials.

Company Information

Company

Insitro

Location

279 East Grand Avenue, Suite 200

San Francisco, California, United States

About

Insitro is an AI therapeutics company focused on drug discovery and development. The company utilizes machine learning techniques to enhance and expedite the process of pharmaceutical research. Insitro aims to transform the way drugs are discovered and developed, improving outcomes in healthcare. It has garnered respect in the biotech industry for its innovative approach.

Don't miss Insitro's next move

Get an email the moment Insitro changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
Emily
Likely contact at this company
••••••••@••••••••

See Emily's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Insitro's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Insitro changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.